Business Description
Exact Therapeutics AS
ISIN : NO0010852213
Share Class Description:
OSL:EXTX: Ordinary SharesCompare
Compare
Traded in other countries / regions
EXTX.Norway56F.Germany IPO Date
2020-07-14Description
Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing Acoustic Cluster Therapy (ACT), a promising non-invasive precision health technology for targeted enhancement of therapeutics. ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.42 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12.2 | |||||
| 3-Year EPS without NRI Growth Rate | 11.7 | |||||
| 3-Year FCF Growth Rate | 9.5 | |||||
| 3-Year Book Growth Rate | -35.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.05 | |||||
| 9-Day RSI | 77.02 | |||||
| 14-Day RSI | 69 | |||||
| 6-1 Month Momentum % | -27.22 | |||||
| 12-1 Month Momentum % | -53.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.02 | |||||
| Quick Ratio | 2.02 | |||||
| Cash Ratio | 1.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.3 | |||||
| Shareholder Yield % | 0.27 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -152.98 | |||||
| ROA % | -113.07 | |||||
| ROIC % | -582.03 | |||||
| ROC (Joel Greenblatt) % | -1174.45 | |||||
| ROCE % | -152.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 11.03 | |||||
| Price-to-Tangible-Book | 11.11 | |||||
| EV-to-EBIT | -3.19 | |||||
| EV-to-EBITDA | -3.33 | |||||
| EV-to-FCF | -3.57 | |||||
| Price-to-Net-Current-Asset-Value | 15 | |||||
| Price-to-Net-Cash | 150 | |||||
| Earnings Yield (Greenblatt) % | -31.3 | |||||
| FCF Yield % | -25.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Exact Therapeutics AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -1.66 | ||
| Beta | 0.02 | ||
| Volatility % | 61.39 | ||
| 14-Day RSI | 69 | ||
| 14-Day ATR (kr) | 0.065202 | ||
| 20-Day SMA (kr) | 5.635 | ||
| 12-1 Month Momentum % | -53.63 | ||
| 52-Week Range (kr) | 4.8 - 12.5 | ||
| Shares Outstanding (Mil) | 32.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Exact Therapeutics AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Exact Therapeutics AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Exact Therapeutics AS Frequently Asked Questions
What is Exact Therapeutics AS(OSL:EXTX)'s stock price today?
The current price of OSL:EXTX is kr6.00. The 52 week high of OSL:EXTX is kr12.50 and 52 week low is kr4.80.
When is next earnings date of Exact Therapeutics AS(OSL:EXTX)?
The next earnings date of Exact Therapeutics AS(OSL:EXTX) is 2025-03-30 Est..
Does Exact Therapeutics AS(OSL:EXTX) pay dividends? If so, how much?
Exact Therapeutics AS(OSL:EXTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers